• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CERo Therapeutics Holdings, Inc. - Common Stock (NQ:CERO)

7.675 -0.085 (-1.10%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 27,060
Open 7.730
Bid (Size) 7.400 (2)
Ask (Size) 7.800 (1)
Prev. Close 7.760
Today's Range 7.250 - 7.764
52wk Range 6.710 - 895.40
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CERo Therapeutics Doses Second Acute Myeloid Leukemia Patient with CER-1236
July 31, 2025
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
June 23, 2025
 
Via Benzinga

Performance

YTD
-93.7%
-93.7%
1 Month
-17.1%
-17.1%
3 Month
-51.4%
-51.4%
6 Month
-80.8%
-80.8%
1 Year
-97.6%
-97.6%

More News

Read More
Top movers in Monday's after hours session
June 23, 2025
Via Chartmill
CERo Therapeutics Holdings, Inc. Announces First Patient Completes Dose-Limiting Toxicity Observation Period with No Reported DLTs in Phase 1 Trial of CER-1236
June 23, 2025
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
Which stocks are experiencing notable movement on Wednesday?
June 18, 2025
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 18, 2025
Via Benzinga
Dow Surges 150 Points; Korn Ferry Earnings Top Views
June 18, 2025
Via Benzinga
Topics Stocks
Here are the top movers in Wednesday's session.
June 18, 2025
Via Chartmill
Which stocks are gapping on Wednesday?
June 18, 2025
Via Chartmill
Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
June 18, 2025
Via Benzinga
Topics Cannabis
Wondering what's happening in today's pre-market session?
June 18, 2025
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 18, 2025
Via Benzinga
US Stocks Likely To Open Higher Despite Trump's 'Unconditional Surrender' Call: All Eyes On Powell As Experts Predict Inflation Will Limit Fed's Rate Cut Capacity
June 18, 2025
Via Benzinga
Topics Economy Government
Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket
June 18, 2025
Via Benzinga
Dow Dips Around 300 Points As Israel-Iran Conflict Escalates: Investor Sentiment Declines, Fear & Greed Index Moves To 'Neutral' Zone
June 18, 2025
Via Benzinga
Topics Stocks
Cero Therapeutics Rockets On FDA Orphan Drug Status For Blood Cancer Drug; Retail Bulls Feel Stock 'Still Has A Few Pumps Left'
June 17, 2025
Via Stocktwits
Top movers in Tuesday's after hours session
June 17, 2025
Via Chartmill
Crude Oil Rises Sharply; Jabil Earnings Top Views
June 17, 2025
Via Benzinga
US Stocks Lower; Retail Sales Decline In May
June 17, 2025
Via Benzinga
Peraso Inc (NASDAQ: PRSO) Deploys Stealth Tech Shipment for Military Use – Tapping $500M NATO Market – More Stocks Inside
June 17, 2025
Via AB Newswire
Which stocks are gapping on Tuesday?
June 17, 2025
Via Chartmill
What's Going On With Cero Therapeutics Stock Tuesday?
June 17, 2025
Via Benzinga
Get insights into the top gainers and losers of Tuesday's pre-market session.
June 17, 2025
Via Chartmill
CERo Therapeutics Holdings, Inc. Announces FDA Orphan Drug Designation Granted to CER-1236 for the Treatment of Acute Myeloid Leukemia (AML)
June 17, 2025
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire
CERo Therapeutics Holdings, Inc. Announces Reverse Stock Split
June 11, 2025
From CERo Therapeutics Holdings, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is CERo Therapeutics Holdings, Inc. - Common Stock publicly traded?
Yes, CERo Therapeutics Holdings, Inc. - Common Stock is publicly traded.
What exchange does CERo Therapeutics Holdings, Inc. - Common Stock trade on?
CERo Therapeutics Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CERo Therapeutics Holdings, Inc. - Common Stock?
The ticker symbol for CERo Therapeutics Holdings, Inc. - Common Stock is CERO on the Nasdaq Stock Market
What is the current price of CERo Therapeutics Holdings, Inc. - Common Stock?
The current price of CERo Therapeutics Holdings, Inc. - Common Stock is 7.675
When was CERo Therapeutics Holdings, Inc. - Common Stock last traded?
The last trade of CERo Therapeutics Holdings, Inc. - Common Stock was at 08/01/25 04:00 PM ET
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap